ChartRow logo
Share this page
TMO
$654.80+0.35%
as of close, Oct 2, 2026
☾ AH $654.80 +0.35%
PeersMRNALLYUNHJNJMRKAMGN

TMO financial statements

The full income statement, balance sheet, and cash-flow statement for Thermo Fisher Scientific Inc. (TMO), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 382.0M2024-09 382.5M2024-12 377.3M2025-03 377.5M2025-06 377.6M2025-09 375.7M2025-12 371.5M2026-03 371.6M2026-06 369.7M-3.2% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue44.6B+3.9%42.9B+0.1%42.9B-4.6%44.9B+14.5%39.2B+21.7%
Research & development1.40B+0.5%1.39B+4.0%1.34B-9.1%1.47B+4.6%1.41B+19.1%
Selling, general & administrative8.73B+1.6%8.60B+1.8%8.45B-6.1%8.99B+12.3%8.01B+15.5%
Restructuring197M+103.1%97.0M-50.0%194M+185.3%68.0M+83.8%37.0M-27.5%
Amortization of intangibles1.73B-11.4%1.95B-16.5%2.34B-2.4%2.40B+36.0%1.76B+5.6%
Operating income7.75B+5.6%7.34B+7.0%6.86B-18.3%8.39B-16.3%10.0B+28.7%
Interest expense1.42B+2.1%1.39B+1.1%1.38B+89.4%726M+35.4%536M-3.1%
Interest & investment income993M-7.9%1.08B+22.6%879M+223.2%272M+532.6%43.0M-33.8%
Other non-operating income-12.0M-200.0%12.0M+118.5%-65.0M+37.5%-104M+85.0%-694M-813.2%
Equity-method income-41.0M+2.4%-42.0M+28.8%-59.0M+65.7%-172M-4200.0%-4.00M-33.3%
Pre-tax income7.31B+3.9%7.04B+11.7%6.30B-19.6%7.83B-11.4%8.84B+22.4%
Income tax547M-16.7%657M+131.3%284M-59.6%703M-36.6%1.11B+30.5%
6.70B+5.8%6.33B+5.7%6.00B-13.9%6.96B-9.9%7.73B+21.2%
Net income to non-controlling interest17.0M+466.7%3.00M+107.5%-40.0M-500.0%10.0M+233.3%3.00M+50.0%
Net income to common—6.33B+5.7%6.00B-13.7%6.95B-10.0%7.72B+21.2%
$17.74+7.3%$16.53+7.0%$15.45-12.4%$17.63-9.4%$19.46+21.9%
EPS (basic)$17.77+7.2%$16.58+6.8%$15.52-12.6%$17.75-9.5%$19.62+21.9%
Weighted-avg shares (basic)377M-1.3%382M-1.0%386M-1.5%392M-0.5%394M-0.5%
Weighted-avg shares (diluted)378M-1.3%383M-1.3%388M-1.5%394M-0.8%397M-0.5%
Dividends per share$1.72+10.3%$1.56+11.4%$1.40+16.7%$1.20+15.4%$1.04+18.2%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
28.7B+29.7%22.1B-10.0%24.6B-2.5%25.2B+25.4%20.1B-8.4%
Cash & equivalents9.85B+145.7%4.01B-50.4%8.08B-5.2%8.52B+90.4%4.48B-56.6%
Short-term investments253M-83.8%1.56B+51933.3%3.00M——
Accounts receivable8.90B+8.7%8.19B-0.4%8.22B+1.3%8.12B+1.7%7.98B+38.9%
Inventory5.42B+9.0%4.98B-2.2%5.09B-9.7%5.63B+11.5%5.05B+25.4%
Other current assets2.61B+33.0%1.96B+11.8%1.76B+6.9%1.64B+0.2%1.64B+45.0%
110B+13.4%97.3B-1.4%98.7B+1.6%97.2B+2.1%95.1B+37.8%
Property, plant & equipment10.6B+13.5%9.31B-1.5%9.45B+1.8%9.28B+11.4%8.33B+41.0%
Operating lease right-of-use1.45B-2.8%1.49B-4.3%1.56B-2.3%1.59B+4.0%1.53B+97.5%
Goodwill49.4B+7.7%45.9B+4.2%44.0B+6.9%41.2B-1.7%41.9B+61.0%
Intangible assets15.8B+2.0%15.5B-6.8%16.7B-4.4%17.4B-13.3%20.1B+58.6%
Other non-current assets5.87B+30.7%4.49B+12.3%4.00B-0.2%4.01B-13.6%4.64B+88.8%
15.2B+13.9%13.3B-4.9%14.0B-17.6%17.0B+26.6%13.4B+30.4%
Accounts payable3.62B+17.6%3.08B+7.2%2.87B-15.1%3.38B+17.9%2.87B+31.8%
Deferred revenue2.71B-5.0%2.85B+6.1%2.69B+3.4%2.60B-2.0%2.65B+108.9%
Short-term & current debt3.53B+59.6%2.21B-38.7%3.61B-35.3%5.58B+119.9%2.54B-3.5%
Current lease liability275M+5.4%261M-0.8%263M-3.3%272M+2.3%266M+44.6%
Other current liabilities3.33B+4.1%3.20B-1.4%3.25B-3.2%3.35B+13.7%2.95B+27.5%
Long-term debt39.2B+26.1%31.1B-10.5%34.7B+1.3%34.3B-1.1%34.7B+81.5%
Deferred revenue (non-current)1.18B+4.0%1.14B-24.1%1.50B+27.1%1.18B-4.8%1.24B+62.3%
Non-current lease liability1.20B-3.6%1.24B-0.4%1.24B-5.3%1.31B+9.1%1.20B+92.2%
Operating lease liability (total)1.47B-2.1%1.50B-0.4%1.51B-4.9%1.58B+7.9%1.47B+81.4%
Finance lease liability (total)213M+5.4%202M+6.3%190M-9.5%210M+5.0%200M+2757.1%
Deferred tax liabilities1.49B+17.7%1.27B-34.0%1.92B-32.5%2.85B-25.7%3.84B+113.9%
Other non-current liabilities4.27B+7.1%3.99B-14.1%4.64B+9.5%4.24B-6.7%4.54B+36.3%
53.4B+7.7%49.6B+6.1%46.7B+6.3%44.0B+7.8%40.8B+18.2%
Preferred stock0.000.000.000.000.00
Common stock445M+0.2%444M+0.5%442M+0.2%441M+0.5%439M+0.5%
Additional paid-in capital18.6B+3.3%18.0B+3.9%17.3B+3.2%16.7B+3.5%16.2B+3.8%
Retained earnings59.2B+11.4%53.1B+12.1%47.4B+13.0%41.9B+18.3%35.4B+26.0%
Treasury stock22.3B+16.0%19.2B+27.0%15.1B+25.9%12.0B+34.7%8.92B+30.9%
Accumulated other comprehensive income-2.45B+9.2%-2.70B+16.3%-3.22B-4.0%-3.10B-33.1%-2.33B+17.0%
Non-controlling interest7.00M+121.2%-33.0M-200.0%-11.0M-120.4%54.0M-12.9%62.0M+520.0%
Total equity incl. non-controlling53.4B+7.8%49.6B+6.1%46.7B+6.1%44.0B+7.8%40.9B+18.4%
Total liabilities & equity110B+13.4%97.3B-1.4%98.7B+1.6%97.2B+2.1%95.1B+37.8%
Common shares issued445M+0.3%444M+0.4%442M+0.3%441M+0.3%439M+0.5%
Common shares outstanding445M+0.2%444M+0.5%442M+0.2%441M+0.5%439M+0.5%
Shares outstanding (cover)371M-1.5%377M-1.1%381M-1.1%385M-1.5%391M-0.7%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
7.82B-9.8%8.67B+3.1%8.41B-8.2%9.15B-1.7%9.31B+12.3%
Depreciation & amortization2.78B-10.6%3.11B-8.7%3.41B+0.7%3.38B+30.4%2.59B+11.5%
Intangible amortization1.73B-11.4%1.95B-16.5%2.34B-2.4%2.40B+36.0%1.76B+5.6%
Share-based compensation310M+3.0%301M+8.3%278M-9.4%307M+33.5%230M+17.3%
Deferred income taxes-639M+47.1%-1.21B+7.0%-1.30B-30.4%-997M-54.6%-645M-139.8%
Change in receivables426M+149.1%171M+297.7%43.0M-90.0%430M+110.8%204M-84.3%
Change in inventory74.0M+174.1%27.0M+104.5%-598M-172.5%825M-22.5%1.06B+109.6%
Change in payables421M+98.6%212M+142.4%-500M-177.2%648M+35.3%479M+711.9%
-4.05B+30.7%-5.84B-13.6%-5.14B-138.2%-2.16B+90.2%-21.9B-1352.5%
Capital expenditure1.52B+8.9%1.40B-5.3%1.48B-34.1%2.24B-11.1%2.52B+71.2%
Free cash flow6.29B-13.4%7.27B+4.9%6.93B+0.2%6.91B+1.8%6.79B-0.4%
Acquisitions4.04B+28.9%3.13B-14.4%3.66B+9284.6%39.0M-99.8%19.4B+50939.5%
Purchases of investments383M-88.7%3.40B+1532.7%208M+300.0%52.0M—
Sales/maturities of investments1.56B-11.6%1.77B+11700.0%15.0M-87.1%116M—
Proceeds from sale of PP&E44.0M-22.8%57.0M-34.5%87.0M+262.5%24.0M+20.0%20.0M+150.0%
Other investing activities-21.0M-162.5%-8.00M+75.8%-33.0M-65.0%-20.0M-147.6%42.0M+600.0%
1.80B+126.5%-6.79B-87.5%-3.62B-28.9%-2.81B-142.7%6.58B+586.2%
Long-term debt issued7.76B+544.4%1.20B-79.7%5.94B+86.1%3.19B-82.4%18.1B+423.6%
Long-term debt repaid2.41B-33.1%3.61B-37.6%5.78B+1441.9%375M-96.8%11.7B+1553.2%
Common stock issued0.000.000.000.000.00
Common stock repurchased3.00B-25.0%4.00B+33.3%3.00B+0.0%3.00B+50.0%2.00B+33.3%
Dividends paid636M+9.1%583M+11.5%523M+14.9%455M+15.2%395M+17.2%
Other financing activities90.0M-53.8%195M+248.2%56.0M+722.2%-9.00M-113.8%65.0M+41.3%
FX effect on cash
————194M+10.2%
Net change in cash5.84B+243.9%-4.06B-822.0%-440M-110.9%4.05B+169.2%-5.84B-173.9%
Interest paid1.61B+2.7%1.57B+13.4%1.39B+107.6%667M+20.2%555M+17.8%
Income taxes paid1.78B-3.2%1.83B+23.8%1.48B+20.1%1.23B-43.4%2.18B+64.8%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap215B+9.7%196B-4.3%205B-5.0%216B-17.3%261B+42.3%
P/E32.1×+3.6%31.0×-10.5%34.6×+12.9%30.7×-9.2%33.8×+17.4%
P/S4.8×+5.5%4.6×-3.1%4.7×-3.4%4.9×-26.5%6.7×+16.9%
P/B4.0×+1.8%4.0×-12.5%4.5×-8.8%5.0×-22.5%6.4×+20.4%
P/FCF34.2×+26.7%27.0×-13.8%31.3×-18.8%38.6×+0.3%38.4×+42.9%
Earnings yield3.1%-3.5%3.2%+11.8%2.9%-11.5%3.3%+10.2%3.0%-14.8%
FCF yield2.9%-21.0%3.7%+16.0%3.2%+23.1%2.6%-0.3%2.6%-30.0%
Dividend yield0.30%-1.0%0.30%+13.7%0.26%+21.0%0.22%+39.8%0.16%-17.5%
Source filing10-K10-K10-K10-K10-K

About this data

Source: TMO’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TMO filings on SEC EDGAR → Not investment advice.